Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 39

References for PMC Articles for PubMed (Select 19141710)

1.

The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist.

Jaakola VP, Griffith MT, Hanson MA, Cherezov V, Chien EY, Lane JR, Ijzerman AP, Stevens RC.

Science. 2008 Nov 21;322(5905):1211-7. doi: 10.1126/science.1164772. Epub 2008 Oct 2.

2.

Ligand-specific contribution of the N terminus and E2-loop to pharmacological properties of the histamine H1-receptor.

Strasser A, Wittmann HJ, Seifert R.

J Pharmacol Exp Ther. 2008 Sep;326(3):783-91. doi: 10.1124/jpet.108.140913. Epub 2008 Jun 24.

3.

Recent improvements in the development of A(2B) adenosine receptor agonists.

Baraldi PG, Tabrizi MA, Fruttarolo F, Romagnoli R, Preti D.

Purinergic Signal. 2008 Dec;4(4):287-303. doi: 10.1007/s11302-008-9097-z. Epub 2008 Apr 29.

4.

Design of (N)-methanocarba adenosine 5'-uronamides as species-independent A3 receptor-selective agonists.

Melman A, Gao ZG, Kumar D, Wan TC, Gizewski E, Auchampach JA, Jacobson KA.

Bioorg Med Chem Lett. 2008 May 1;18(9):2813-9. doi: 10.1016/j.bmcl.2008.04.001. Epub 2008 Apr 4.

5.

Allosteric modulation of heterodimeric G-protein-coupled receptors.

Milligan G, Smith NJ.

Trends Pharmacol Sci. 2007 Dec;28(12):615-20. Epub 2007 Nov 19. Review.

PMID:
18022255
6.

High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor.

Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, Choi HJ, Kuhn P, Weis WI, Kobilka BK, Stevens RC.

Science. 2007 Nov 23;318(5854):1258-65. Epub 2007 Oct 25.

7.

Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B adenosine receptors.

Eckle T, Krahn T, Grenz A, Köhler D, Mittelbronn M, Ledent C, Jacobson MA, Osswald H, Thompson LF, Unertl K, Eltzschig HK.

Circulation. 2007 Mar 27;115(12):1581-90. Epub 2007 Mar 12.

8.

The highly conserved DRY motif of class A G protein-coupled receptors: beyond the ground state.

Rovati GE, Capra V, Neubig RR.

Mol Pharmacol. 2007 Apr;71(4):959-64. Epub 2006 Dec 27. Review.

9.

Adenosine inhibits tumor necrosis factor-alpha release from mouse peritoneal macrophages via A2A and A2B but not the A3 adenosine receptor.

Kreckler LM, Wan TC, Ge ZD, Auchampach JA.

J Pharmacol Exp Ther. 2006 Apr;317(1):172-80. Epub 2005 Dec 9.

10.

New, non-adenosine, high-potency agonists for the human adenosine A2B receptor with an improved selectivity profile compared to the reference agonist N-ethylcarboxamidoadenosine.

Beukers MW, Chang LC, von Frijtag Drabbe Künzel JK, Mulder-Krieger T, Spanjersberg RF, Brussee J, IJzerman AP.

J Med Chem. 2004 Jul 15;47(15):3707-9.

PMID:
15239649
11.

Antagonist pharmacology of adenosine A2B receptors from rat, guinea pig and dog.

Fozard JR, Baur F, Wolber C.

Eur J Pharmacol. 2003 Aug 15;475(1-3):79-84.

PMID:
12954362
12.

A(2B) adenosine receptors increase cytokine release by bronchial smooth muscle cells.

Zhong H, Belardinelli L, Maa T, Feoktistov I, Biaggioni I, Zeng D.

Am J Respir Cell Mol Biol. 2004 Jan;30(1):118-25. Epub 2003 Jul 10.

PMID:
12855406
13.

Structure-activity relationships at human and rat A2B adenosine receptors of xanthine derivatives substituted at the 1-, 3-, 7-, and 8-positions.

Kim SA, Marshall MA, Melman N, Kim HS, Müller CE, Linden J, Jacobson KA.

J Med Chem. 2002 May 23;45(11):2131-8.

PMID:
12014951
14.

Differential expression of adenosine receptors in human endothelial cells: role of A2B receptors in angiogenic factor regulation.

Feoktistov I, Goldstein AE, Ryzhov S, Zeng D, Belardinelli L, Voyno-Yasenetskaya T, Biaggioni I.

Circ Res. 2002 Mar 22;90(5):531-8.

15.

Human A(2A) adenosine receptors: high-affinity agonist binding to receptor-G protein complexes containing Gbeta(4).

Murphree LJ, Marshall MA, Rieger JM, MacDonald TL, Linden J.

Mol Pharmacol. 2002 Feb;61(2):455-62.

16.

Cardiac effects of adenosine in A(2A) receptor knockout hearts: uncovering A(2B) receptors.

Morrison RR, Talukder MA, Ledent C, Mustafa SJ.

Am J Physiol Heart Circ Physiol. 2002 Feb;282(2):H437-44.

17.

International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors.

Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J.

Pharmacol Rev. 2001 Dec;53(4):527-52. Review.

18.

[3H]MRS 1754, a selective antagonist radioligand for A(2B) adenosine receptors.

Ji X, Kim YC, Ahern DG, Linden J, Jacobson KA.

Biochem Pharmacol. 2001 Mar 15;61(6):657-63.

PMID:
11266650
19.

Structure and function of adenosine receptors and their genes.

Fredholm BB, Arslan G, Halldner L, Kull B, Schulte G, Wasserman W.

Naunyn Schmiedebergs Arch Pharmacol. 2000 Nov;362(4-5):364-74. Review.

PMID:
11111830
20.

Netrin-1-mediated axon outgrowth and cAMP production requires interaction with adenosine A2b receptor.

Corset V, Nguyen-Ba-Charvet KT, Forcet C, Moyse E, Chédotal A, Mehlen P.

Nature. 2000 Oct 12;407(6805):747-50.

PMID:
11048721
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk